Anti-DNA antibody subpopulations and lupus nephritis

被引:46
作者
Rekvig, OP [1 ]
Kalaaji, M
Nossent, H
机构
[1] Univ Tromso, Fac Med, Inst Med Biol, Dept Biochem, N-9037 Tromso, Norway
[2] Univ Tromso, Inst Clin Med, Dept Rheumatol, N-9037 Tromso, Norway
[3] Univ Tromso Hosp, Dept Rheumatol, N-9038 Tromso, Norway
关键词
anti-DNA antibodies; nephritis; nucleosomes; systemic lupus erythematosus; cross-recations;
D O I
10.1016/S1568-9972(03)00081-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As a consequence of increased insight into the cellular and molecular mechanisms responsible for induction of B cell and T cell autoinimunity to DNA and nucleosomes, there is an obvious need to reconsider the dogma stating that anti-dsDNA antibodies serve as marker antibodies for SLE and also that anti-dsDNA antibodies per se are responsible for the initiation of lupus nephritis. Given that the potential to produce anti-dsDNA antibodies is an inherent property of the normal immune system and that few anti-DNA antibodies have nephritogenic potential, we must try to solve the problem whether it is avidity for DNA, specificity for unique DNA structures or cross-reactivity with non-DNA molecules, that make such antibodies pathogenic and thus potential markers for SLE and lupus nephritis. In this review, we will summarize contemporary problems related to these questions; (1) try to focus on phenotypic differences with respect to the ability to produce anti-dsDNA antibodies between individuals suffering from SLE and those not belonging to this diagnostic group, and (2) to describe differences between pathogenic and non-pathogenic anti-dsDNA antibodies. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 38 条
[1]   T cell Autoimmunity to histones and nucleosomes is a latent property of the normal immune system [J].
Andreassen, K ;
Bendiksen, S ;
Kjeldsen, E ;
Van Ghelue, M ;
Arnesen, E ;
Rekvig, OP .
ARTHRITIS AND RHEUMATISM, 2002, 46 (05) :1270-1281
[2]   Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis [J].
Berden, JHM ;
Licht, R ;
van Bruggen, MCJ ;
Tax, WJM .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (03) :299-306
[3]   Lupus nephritis - Discussion [J].
Berden, JHM ;
Madias, NE ;
Broumand, B ;
Klinger, M ;
Sonkodi, S ;
Nayak, KS ;
Hruby, Z .
KIDNEY INTERNATIONAL, 1997, 52 (02) :538-558
[4]  
Berden JHM, 2002, J NEPHROL, V15, pS1
[5]   Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein [J].
Boackle, SA ;
Holers, VM ;
Chen, XJ ;
Szakonyi, G ;
Karp, DR ;
Wakeland, EK ;
Morel, L .
IMMUNITY, 2001, 15 (05) :775-785
[6]   THE SITE AND STAGE OF ANTI-DNA B-CELL DELETION [J].
CHEN, C ;
NAGY, Z ;
RADIC, MZ ;
HARDY, RR ;
HUSZAR, D ;
CAMPER, SA ;
WEIGERT, M .
NATURE, 1995, 373 (6511) :252-255
[7]  
CRAFT JE, 1987, J RHEUMATOL, V14, P106
[8]   The CD28-B7 costimulatory pathway and its role in autoimmune disease [J].
Daikh, D ;
Wofsy, D ;
Imboden, JB .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 62 (02) :156-162
[9]   Autoantibodies interact directly with distinct glomerular and vascular cell surface antigens [J].
DAndrea, DM ;
CoupayeGerard, B ;
Kleyman, TR ;
Foster, MH ;
Madaio, MP .
KIDNEY INTERNATIONAL, 1996, 49 (05) :1214-1221
[10]   Triggers for anti-chromatin autoantibody production in SLE [J].
Dieker, JWC ;
van der Vlag, J ;
Berden, JHM .
LUPUS, 2002, 11 (12) :856-864